[Secure Your Spot] Register today for Single-cell profiling of genome-editing alterations and functional outcomes in CRISPR-engineered cells. Whether you can make it live, or not, register to gain access. watch.getcontrast.io/register/mis...

Attending #ASH2025? Bring any curiosity you might have about the world of Single-cell to booth 2129. You can snag an appt at this link if you prefer to manage your time - go.missionbio.com/ASH2025

[Press Release] “The DNA+RNA assay provides powerful resolution into the mutational landscape and cell states within leukemia,” says Bobby Bowman, PhD, Assistant Professor. Read the full release here: missionbio.com/press/target...

Discover our webinars right here: watch.getcontrast.io/missionbio

[blog post] Adapting Tapestri for Single-Cell RNA-Seq: Customer Stories. missionbio.com/company/blog...

[Upcoming Webinar] See how single-cell DNA + DNA methylation + surface protein profiling with scTAM-seq (on Tapestri) dissects treatment response in MDS/AML using sequential patient bone-marrow samples collected during targeted therapy. watch.getcontrast.io/register/mis...

Happy Peppermint Mocha Day to everyone celebrating! Yes, it's true, like the Pumpkin Spice Latte, it pairs wonderfully with our Single-cell Sequencing 101 eBook! 🔗 - missionbio.com/resources/eb...

To overcome cellular heterogeneity, the critical challenge driving drug resistance in oncology and impacting safety in cell & gene therapy, targeted single-cell DNA and RNA analysis is the key to linking genetic drivers to their functional expression in every cell. missionbio.com/company/blog...

[Open Paper] Analysis of genomic heterogeneity and the mutational landscape in cutaneous squamous cell carcinoma through multi-patient-targeted single-cell DNA sequencing. bmccancer.biomedcentral.com/articles/10....

In this blog post, discover how single-cell multi-omics helps you see what bulk methods miss. By linking DNA, RNA, and protein in the same cell, researchers can spot relapse earlier, follow clonal evolution, & shape better therapies for cancer and cell & gene therapy. missionbio.com/company/blog...

🚨 [New Blog] 🚨 Discover how by combining single-cell targeted DNA and RNA analysis, Mission Bio’s Tapestri platform now lets researchers connect genotype with function for a more complete view of disease biology. 🖊️ - Authored by Jacqueline Marin Read here: missionbio.com/company/blog...

📣 [New Press Release] - Mission Bio is accelerating the development of single-cell tri-omics to unlock deeper insights in cancer research and treatment. Read the full release here: missionbio.com/press/equity...

Last call for savings! 📣 Mission Bio is offering limited-time discounts on Tapestri® kits and warranties to help academic and non-profit labs stretch their budgets further — and still generate high-impact single-cell data. Learn more 👉 bit.ly/453RcBr

We're excited to announce our newest advancement in precision oncology: the Single-Cell Genotype and Targeted Gene Expression assay! This solution enables simultaneous profiling of genotype and targeted gene expression in over 10,000 cells 🎉 Learn more ➡️ bit.ly/4ktWgUE

💸Budget tight? We’ve got your back. Mission Bio is offering limited-time discounts on Tapestri® kits and warranties to help academic and non-profit labs stretch their budgets further — and still generate high-impact single-cell data. Learn more 👉 bit.ly/453RcBr

Published today in @nature.com, researchers from @crg.eu and @irbbarcelona.org utilized Tapestri to develop EPI-clone, which tracks clonal dynamics in hematopoiesis with naturally occurring DNA methylation patterns. Learn more here ➡️ bit.ly/4drZc12

#ASGCT2025 is in full swing! We're having a blast in New Orleans meeting everyone and sharing how Tapestri is advancing genome editing validation with single-cell precision. Swing by Booth #1749 to say hello to our team! 👋

At #ASGCT2025? Don’t miss our poster on advancing genome editing validation with single-cell precision 🧬 Comprehensive On- and Off-target Validation Using Integrated rhAmpSeq and Targeted DNA Resequencing Single-Cell Technology 📅 May 15 | 5:30 PM CT Learn more here ➡️ bit.ly/4jS33Hc

🎉 We're headed to the Big Easy! Join us next week in New Orleans for @asgct.bsky.social #ASGCT2025 🎉 Visit Mission Bio at Booth #1749 to learn more about how Tapestri is advancing #cgt characterization 🧬 Check out the *can't-miss* oral and poster presentations here ➡️ bit.ly/3SrruPD

Our partnership with Integrated DNA Technologies is built on the principle of therapeutic safety— bringing single-cell resolution and unmatched precision to genome editing analysis. Read the full story here 👉 bit.ly/3GBbCro

Bulk sequencing and traditional assays miss critical details that impact the safety and efficacy of cell therapies. 🧐 With the Tapestri, you can interrogate zygosity, detect off-target effects, and assess immunophenotype—all in one assay. Learn more ➡️ bit.ly/42kjBS5

Our team is having an *AWSOM* time in Atlanta today at the 4th annual Atlanta Workshop of Single-cell Omics. If you're attending, be sure to swing by our table to say hi! 👋 Learn more about the Tapestri platform here ➡️ missionbio.com/products/pla...

Actionable Insights, Accelerated Outcomes 💪 Get the right drug to market faster with PAD services. Learn more about PAD services for drug development here ➡️ bit.ly/4ia8uj2

Your partner at every step 🤝 From assay design to sample analysis and data interpretation, the PAD Services Team is here to help. Learn more ➡️ bit.ly/3FLtsYj

🚨 Last chance to register!🚨 Join us tomorrow to learn how researchers from @cincychildrens.bsky.social utilized single-cell DNA + Fusion multi-omic analysis for acute leukemias 📅 Thursday, February 27 ⏰ 11:30a ET | 8:30a PT Register here ➡️ bit.ly/4131uPD

[Live Webinar] Learn how researchers from @cincychildrens.bsky.social utilized single-cell DNA + Fusion multi-omic analysis for acute leukemias 📅 Thursday, February 27 ⏰ 11:30a ET | 8:30a PT Register now to save your spot! ➡️ bit.ly/4131uPD

📌 📅 Save the date! Join us Thursday, January 30 for a live webinar with Dr. Nils Wellhausen of @upenn.edu School of Medicine. He'll be discussing how epitope editing enables safe, CD45-directed CAR-T therapies for blood cancers. Register here ➡️ missionbio.zoom.us/webinar/regi...